Glucose-6-Phosphate dehydrogenase deficiency: Report of a WHO working group
No Thumbnail Available
Cite
Pan American Health Organization. (1989). Glucose-6-Phosphate dehydrogenase deficiency: Report of a WHO working group [Journal articles]. https://iris.paho.org/handle/10665.2/45012
Date
1989
Document Number
WHO/HPD/WG/G6PD/85.9
ISBN
eISBN
ISSN
DOI
Other Language Versions
Description
The information contained within this document is updated to March 1989
WHO Working Group on G6PD Deficiency. World Health Organization; 3-4 Sept. 1985
WHO Working Group on G6PD Deficiency. World Health Organization; 3-4 Sept. 1985
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item The process of health policy development : Report of a working group on the development of subnational policies for health [meeting held in Lugano, Switzerland, 30 September - 1 October 1991](1992)Summary report available in English, French, German and RussianItem Meeting of the Pediatric Cancer Working Group (Washington, D.C., 2-3 February 2017)(PAHO, 2017)About 9,000 children die of cancer every year in the Americas, where cancer is the leading cause of death from disease among children under 15. In high-income countries, childhood cancer mortality has been reduced significantly and survival rates are 80% or higher. However, in Latin America and the Caribbean (LAC), pediatric cancer survival rates are significantly lower than in high-income countries, due to the gaps in access to early diagnosis and effective treatment. In order to close this gap it is essential to foster collaboration among governments, civil society, and academic institutions—including international cooperation and South-South collaboration. This will help LAC countries to develop strategies to improve early diagnosis and treatment of pediatric cancer. Along these lines, the PAHO Pediatric Cancer Working Group is trying to improve access to care for children with cancer and to reduce inequities associated with their prognosis in LAC. The Working Group, formed in 2016 on the heels of a policy dialogue by the Union for International Cancer Control (UICC), gathered the leading pediatric oncologists from public health institutions in LAC, as well as representatives from Canada’s Hospital for Sick Children, the University of Chile, the University of the West Indies, and UICC. To first better understand the situation, barriers, and challenges within health systems to better care for children with cancer, the Working Group is conducting an analysis of childhood cancer care and outcomes in LAC, coordinated by the University of Chile. Through a key informant survey and interviews, information is being collected on governance, financing, delivery of treatment and care, and surveillance of childhood cancer. The analysis will lead to the identification of successful models of childhood cancer care for the Region, and will form the basis upon which feasible and sustainable strategies will be suggested to improve care for children with cancer in the Region. PAHO organized this first face-to-face meeting of the Working Group in order to discuss that analysis and determine future actions. The meeting included 33 professionals from 22 countries of the Americas, including representatives of Ministries of Health, children’s hospitals, academic institutions, and international organizations. The goal was to strengthen the group, identify possible areas of collaboration, and become an element of support for the development and improvement of pediatric cancer programs in LAC.Item Síntesis de evidencia para intervenciones en COVID-19: informes de actualización de la Comisión Nacional de Evaluación de Tecnologías de Salud de Argentina(2023)[RESUMEN]. Este informe tiene por objetivo exponer el trabajo realizado sobre el diseño, la publicación y el impacto de las actualizaciones para intervenciones en COVID-19 basadas en la evidencia, para brindar síntesis de evi- dencia actualizadas a partir de revisiones sistemáticas vivas sobre intervenciones terapéuticas para dar soporte en la toma de decisiones. Para ello, se generó un grupo específico de trabajo en el ámbito de la Comisión Nacional de Evaluación de Tecnologías de Salud (CONETEC) en el Ministerio de Salud de Argentina en colaboración con la Organización Panamericana de la Salud (OPS). Se diseñó una metodología para ela- borar y publicar documentos de evaluación orientados a dar apoyo en la toma de decisiones. Estos informes de actualización se respaldaron en la exploración de tres dominios: los efectos en la salud, la factibilidad de la implementación y las recomendaciones basadas en evidencia. Las conclusiones se adaptaron en un esquema semaforizado según el balance entre los beneficios y los aspectos negativos para los distintos esce- narios clínicos, a fin de mejorar su interpretación y aplicación. Durante el año 2021 se publicaron 16 informes de síntesis de evidencia (13 originales y 3 actualizaciones completas) que recibieron un destacado número consultas desde la página web de CONETEC y la Base Regional de Informes de Evaluación de Tecnologías en Salud de las Américas (BRISA). Así se hizo visible la necesidad de disponer de resúmenes de evidencia robustos, actualizados y confiables con adaptación al contexto de aplicación en el sistema sanitario del país. El desafío se presenta, además, en la actualización constante de la información, la diseminación apropiada y el sostenimiento en la rigurosidad en el desarrollo de los informes.Item Programme for Control of Diarrhoeal Diseases: Fifth programme report: 1984-1985(1986)This, the fifth report on the progress of the World Health Organization (WHO) Diarrhoeal Diseases Control (CDD) Programme, describes the activities undertaken by the Programme in the 1984-1985 biennium. The document covers the following activities and programmes. 1) Health Services Component: control strategies, programme activities, collaboration with other WHO programmes and with other agencies. 2) Research Component: research policy and management, activities of scientific working groups, research projects, collaboration with industry, collaborating centres, training courses, collaboration with other agencies and organizations, plans for reorganization of the research component. 3) Information Services. 4) Programme Review Bodies: technical advisory group, management review committee, meeting of interested parties. 5) Programme Resource and Obligations. 6) Programme Publications and Documents - 1984-1985. This document is of interest to international health professionals working with programme evaluation issuesItem